AGENDA
I. LEGISLATION
a. S. 527, Prescription Pricing for the People Act of 2025 (Grassley, Welch, Coons, Tillis, Blumenthal, Hirono)
HELD pursuant to Committee Rule I.3
b. S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. (Cornyn, Blumenthal, Grassley, Durbin)
HELD pursuant to Committee Rule I.3
c. S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. (Cornyn, Blumenthal, Grassley, Durbin)
HELD pursuant to Committee Rule I.3
d. S. 1097, Interagency Patent Coordination and Improvement Act of 2025 (Durbin, Tillis, Grassley, Coons, Welch)
HELD pursuant to Committee Rule I.3
e. S. 1095, Stop STALLING Act (Klobuchar, Grassley, Durbin, Blumenthal, Cruz, Welch, Booker)
HELD pursuant to Committee Rule I.3
f. S. 1096, Preserve Access to Affordable Generics and Biosimilars Act (Klobuchar, Grassley, Durbin, Blumenthal, Welch, Booker)
HELD pursuant to Committee Rule I.3